Log In
BCIQ
Print this Print this
 

FMX-8

  Manage Alerts
Collapse Summary General Information
Company FerruMax Pharmaceuticals Inc.
Description 
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationAnemia
Indication DetailsTreat anemia in patients with end-stage renal disease (ESRD) on hemodialysis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today